EValuation Of poLygenic Scores and CT imAging In Risk Factor Modification in Patients With diabEtes
Recruiting
N/A
Interventional Study
Cardiovascular Diseases
Type 2 Diabetes Mellitus (T2DM)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 40 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 90 (estimated)
- Sponsor
- Monash University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study is a three-arm, parallel-group, randomised controlled trial evaluating the effect of using cardiac CT imaging or polygenic risk score in cardiovascular risk factor modification in patients with diabetes.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age 40 years or older
* Established diagnosis of T2DM
* Having acceptable imaging quality as deemed by the VHI-AICL
* Able to have a PRS calculated
Exclusion Criteria:
* Unable to provide written informed consent.
* Unwilling to be followed for serial evaluation
* Clinically…
Contacts